During the projected period, the global market is expected to grow at a CAGR of about 6% due to the Nonvascular Interventional Radiology Devices Market In relation to that, it is estimated that the global market would generate $24.9 billion in sales in 2022 and will surpass $44.5 billion by 2032. The range of medical …
Monthly Archives: April 2023
At-Home Vaginal pH Test Kit Market | Home test, Bayer AG, Prestige Consumer Healthcare Inc. and GRÜNSPECHT Naturprodukte GmbH | By 2032
The At-Home Vaginal pH Test Kit Market is anticipated to surpass US$ 175 million by 2032, growing at a CAGR of 5.76% from 2022 to 2032 to reach $100 million. The pH of the vaginal discharge is measured using at-home vaginal pH test kits. A qualitative test to determine the imbalanced pH level of the …
Electrophoresis Market is projected to reach US$ 3.5 Billion by 2032 to register a 4.7% CAGR
By the end of 2032, the Electrophoresis Market is anticipated to reach US$ 3.5 billion, with a 4.7% CAGR in sales revenue. The global demand for electrophoresis is anticipated to grow at a 4.7% CAGR from 2022 to 2032, according to Future Market Insights’ most recent industry report, with a market value of over US$ …
Sexually Transmitted Diseases Diagnostics Market is likely to reach US$ 6.4 Billion by 2032 | Exclusive Report by FMI
The sexually transmitted diseases diagnostics market is expected to escalate at a CAGR of 7.9%, from USD 3.8 billion in 2022 to USD 6.4 billion through 2032. The COVID-19 pandemic is a global health threat unmatched by anything that has occurred before, and its impact on sexually transmitted diseases testing is expected to be dire. As a result …
Critical Care Medicines Market | Pfizer Inc., Abbott, Cadila Pharmaceutica, Triveni Chemicals | By 2032
The global Critical Care Medicines Market is predicted to grow gradually between 2022 and 2032 at a CAGR of around 5% to 6%, generating considerable profits. Critical Care Drugs market players – Pfizer Inc., Abbott, Cadila Pharmaceutica, Triveni chemicals, Haffkine Bio-Pharmaceutical Corporation Ltd., Neon Laboratories Limited, among others represent the global Critical Care Drugs market. The market study depicts …
Distance Health Technologies Market is expected to reach US$ 945 Billion by 2032 expanding at a CAGR of 27%
The global Distance Health Technologies Market is predicted to reach a valuation of US$ 945 Bn by 2032 with the market expanding at a CAGR of 27% from 2022 to 2032. Valued at US$ 65 Bn in 2021, the target market will scale up to an estimated US$ 88 Bn in 2022. The rapidly expanding …
Dental Laboratories Market is expected to reach US$ 53.74 Billion by the end of 2032 | FMI Study
[107 Pages Report] According to the latest revised industry analysis from Future Market Insights, the global dental laboratories Market but was valuable US Dollar$ 29.24 Bn Expected to exhibit close CAGR in 2021 5.6, Over the forecast period (2022-2032). In restorative dentistry, the major responsibility of the dental laboratory is to accurately reproduce all the functional and aesthetic requirements that the dentist has established …
Retractable Needle Safety Syringes Market is likely to grow at a steady CAGR of 4.0% between 2022 and 2032 | FMI
[376 Pages Report] As per Future Market Insights’ latest industry analysis, the global retractable needle safety syringes market was valued at around US$ 5.49 Bn in 2021 and is anticipated to reach US$ 8.45 Bn by 2032, exhibiting a CAGR of around 4.0% over the forecast period (2022-2032). Attribute Key Statistics Retractable Needle Safety Syringes Market Base Value (2021) US$ 5.49 Bn Projected Market Size …
Elastography Imaging Market is expected to reach US$ 8.9 Billion by 2032 at a CAGR of 11.2%
The Elastography Imaging Market is expected to reach US$ 3.1 billion in 2022 and US$ 8.9 billion by 2032 as a result of a rise in the popularity of minimally invasive medical procedures. According to FMI, during the projection period from 2022 to 2032, the elastography imaging market is expected to demonstrate the aforementioned growth …
Chronic Disease Management Market is likely to advance at 13.4% CAGR (2022-2032).
[340 Page Report] The market for managing chronic diseases was worth US$ 4,315.3 million in 2022 and is projected to reach US$ 17,267.6 million by 2032, growing at a CAGR of 13.4% during the forecast period. Chronic disease management services are also referred as enhance primary care. This service is provided to the patient suffering …
Continue reading “Chronic Disease Management Market is likely to advance at 13.4% CAGR (2022-2032).”